{"name":"Hyewon Chung","slug":"hyewon-chung","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9WUDAzd1p3eHBRRFJVb2tZMFdhRVdfUHZKTXFrV2N3Zzg2WC1LWnRfRDMxN3hSRWdPRW9ma3dTLVdJSjJzX3luM211Zmd2ZjdrRUc2MkwzWHZ0RThPTmww?oc=5","date":"2025-07-26","type":"pipeline","source":"Nature","summary":"In vivo efficacy of NRL knockdown with cell-penetrating siRNA in retinal degeneration | Scientific Reports - Nature","headline":"In vivo efficacy of NRL knockdown with cell-penetrating siRNA in retinal degeneration | Scientific Reports","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9rZXZJSFdlWjhZRV9pSXotOEJrNzhaejZZTHRwcmJ0eTlmUkJfNHlnX240RVM2NzB0cXFoNFVQSFA1bm51VVNaQ01YYnJRWjJFSzN4T0dtZ19yNFF3YUVR?oc=5","date":"2024-11-18","type":"pipeline","source":"Nature","summary":"Improved safety of chimeric antigen receptor T cells indirectly targeting antigens via switchable adapters - Nature","headline":"Improved safety of chimeric antigen receptor T cells indirectly targeting antigens via switchable adapters","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}